Articles with "smac mimetic" as a keyword



Photo by markusspiske from unsplash

The SMAC mimetic birinapant attenuates lipopolysaccharide-induced liver injury by inhibiting the tumor necrosis factor receptor-associated factor 3 degradation in Kupffer cells.

Sign Up to like & get
recommendations!
Published in 2017 at "Immunology letters"

DOI: 10.1016/j.imlet.2017.02.016

Abstract: It was demonstrated that second mitochondria-derived activator of caspases (SMAC) mimetic inhibites tumor necrosis factor receptor-associated factor 3 (TRAF3) degradation and the mitogen-activated protein kinase (MAPK) signaling pathway activation induced by lipopolysaccharide (LPS) in vitro.… read more here.

Keywords: birinapant; smac mimetic; liver injury; induced liver ... See more keywords
Photo from wikipedia

Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways

Sign Up to like & get
recommendations!
Published in 2018 at "Scientific Reports"

DOI: 10.1038/s41598-018-32517-9

Abstract: DNA damaging therapies can spur the formation of therapy-related cancers, due to mis-repair of lesions they create in non-cancerous cells. This risk may be amplified in patients with impaired DNA damage responses. We disabled key… read more here.

Keywords: dna damage; smac mimetic; damage response; damage ... See more keywords

SBP-0636457, a Novel Smac Mimetic, Cooperates with Doxorubicin to Induce Necroptosis in Breast Cancer Cells during Apoptosis Blockage

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Oncology"

DOI: 10.1155/2022/2390078

Abstract: Breast cancer (BC) is a common health concern worldwide. Doxorubicin (Dox) is a widely used chemotherapeutic agent to treat various cancers, including BC. However, drug resistance and severe side effects often hinder the clinical application… read more here.

Keywords: sbp; sbp 0636457; dox sbp; cancer ... See more keywords
Photo by fusion_medical_animation from unsplash

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.13849

Abstract: Rhabdomyosarcoma (RMS), a neoplasm characterized by undifferentiated myoblasts, is the most common soft tissue tumour in children. Therapeutic resistance is common in RMS and is often caused by acquired defects in the cellular apoptotic program.… read more here.

Keywords: smac mimetic; murine; oncolytic virus; mimetic compounds ... See more keywords
Photo from wikipedia

SMAC Mimetic BV6 Co-Treatment Downregulates the Factors Involved in Resistance and Relapse of Cancer: IAPs and Autophagy

Sign Up to like & get
recommendations!
Published in 2022 at "Biology"

DOI: 10.3390/biology11111581

Abstract: Simple Summary Breast cancer is the most prominent cancer among women. Therapeutic resistance and reoccurrence of cancer after various therapies, such as chemotherapy, radiotherapy etc., is the major cause of death. In various studies, it… read more here.

Keywords: cancer; death; bv6; resistance ... See more keywords